For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250501:nRSA4245Ga&default-theme=true
RNS Number : 4245G Bridgepoint Group plc 01 May 2025
Bridgepoint Group plc
("Bridgepoint" or the "Company")
Total Voting Rights
In conformity with the Financial Conduct Authority's Disclosure Guidance and
Transparency Rules, Bridgepoint announces that its total issued share capital
as at the close of business on 30 April 2025 comprised:
· 825,300,942 ordinary shares of £0.00005 each with voting rights; and
· 500 deferred shares of £81 each, 1 deferred share of £1, and 1 deferred
share of £0.01, each with no voting rights.
Bridgepoint holds no shares in treasury.
The total number of voting rights in the Company is therefore 825,300,942, and
this figure may be used by shareholders as the denominator for the calculation
by which they will determine if they are required to notify their interest in,
or a change to their interest in, Bridgepoint under the Disclosure Guidance
and Transparency Rules.
ENQUIRIES
Bridgepoint
Analysts and investors Media
Adam Key Christian Jones
adam.key@bridgepointgroup.com (mailto:adam.key@bridgepointgroup.com) christian.jones@bridgepointgroup.com
(mailto:christian.jones@bridgepointgroup.com)
+44 7833 748010
+44 20 7034 3500
FGS Global (Public Relations Adviser to Bridgepoint)
James Murgatroyd / +44 20 7251 3801 / +44 7768 254 911
Anjali Unnikrishnan / +44 20 7251 3801 / +44 7826 534 233
bridgepoint-LON@fgsglobal.com (mailto:bridgepoint-LON@fgsglobal.com)
Legal Entity Identifier (LEI): 213800KFNMVI8PDZX472
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END TVRGIGDSRSDDGUI